Atıf Formatları
Adenovirus mediated NF-kB inhibiting strategies for the treatment of patients with type 1 diabetes
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. ŞANLIOĞLU And Ş. B. YOLDAŞ ÇELİKTEN, "Adenovirus mediated NF-kB inhibiting strategies for the treatment of patients with type 1 diabetes," 13th Annual Congress of European Society of Gene Therapy , Czech Republic, pp.88, 0

ŞANLIOĞLU, S. And YOLDAŞ ÇELİKTEN, Ş. B. Adenovirus mediated NF-kB inhibiting strategies for the treatment of patients with type 1 diabetes. 13th Annual Congress of European Society of Gene Therapy , (Czech Republic), 88.

ŞANLIOĞLU, S., & YOLDAŞ ÇELİKTEN, Ş. B., Adenovirus mediated NF-kB inhibiting strategies for the treatment of patients with type 1 diabetes . 13th Annual Congress of European Society of Gene Therapy (pp.88). , Czech Republic

ŞANLIOĞLU, SALİH, And ŞÜKRAN BURÇAK YOLDAŞ. "Adenovirus mediated NF-kB inhibiting strategies for the treatment of patients with type 1 diabetes," 13th Annual Congress of European Society of Gene Therapy, Czech Republic,

ŞANLIOĞLU, SALİH And YOLDAŞ ÇELİKTEN, ŞÜKRAN B. . "Adenovirus mediated NF-kB inhibiting strategies for the treatment of patients with type 1 diabetes." 13th Annual Congress of European Society of Gene Therapy , Czech Republic, pp.88

ŞANLIOĞLU, S. And YOLDAŞ ÇELİKTEN, Ş. B. . "Adenovirus mediated NF-kB inhibiting strategies for the treatment of patients with type 1 diabetes." 13th Annual Congress of European Society of Gene Therapy , Czech Republic, p.88.

@conferencepaper{conferencepaper, author={SALİH ŞANLIOĞLU And author={ŞÜKRAN BURÇAK YOLDAŞ}, title={Adenovirus mediated NF-kB inhibiting strategies for the treatment of patients with type 1 diabetes}, congress name={13th Annual Congress of European Society of Gene Therapy}, city={}, country={Czech Republic}, year={0}, pages={88} }